672
Participants
Start Date
September 30, 2015
Primary Completion Date
March 13, 2017
Study Completion Date
December 20, 2017
THS 2.2
Ad libitum use of THS 2.2 in an ambulatory setting for 26 weeks.
CC
"Ad libitum use of CC in an ambulatory setting for 26 weeks.~The subject's own preferred brands of CC (no brand restriction) continue to be used as the reference product."
National Clinical Research, Richmond
PMG Research of Cary, Cary
PMG Research of Raleigh, Raleigh
PMG Research of Charlotte, Charlotte
PMG Research of Wilmington, Wilmington
Covance, Inc, Daytona Beach
Compass Research, The Villages
Compass Research, Orlando
Clinical Research West Florida, Tampa
Clinical Research West Florida, Clearwater
PMG Research of Bristol, Bristol
NOCCR, Knoxville
Central Kentucky Research Associate, Lexington
Midwest Clinical Research, Dayton
Celerion Lincoln, Lincoln
Benchmark, Fort Worth
Benchmark, San Angelo
Benchmark, Austin
Celerion Arizona, Tempe
Philip Morris Products S.A.
INDUSTRY